Biotech Companies Attractive Targets for Pharma Companies Looking to Replace Lost Revenues

Five Star Equities Provides Stock Research on Progenics Pharmaceuticals and Repros Therapeutics

Continue Reading

Despite Facing Steep Drops in Coal Shipments Railroads Posting Strong Earnings

Five Star Equities Provides Stock Research on CSX and Kansas City Southern

Continue Reading

Biotech Industry Expected to Experience More Merger & Acquisition Activity in 2013

Five Star Equities Provides Stock Research on Navidea Biopharmaceuticals and Vical

Continue Reading

Recoveries in U.S. Housing and Automotive Markets Help Offset Drops in Coal Demand for Railroad Companies

Five Star Equities Provides Stock Research on Norfolk Southern and Union Pacific

Continue Reading

Biotech M&A Activity to Rise in 2013 as Pharma Companies Look to Replace Lost Revenues

Five Star Equities Provides Stock Research on AVEO Pharmaceuticals and Repros Therapeutics

Continue Reading

Utilities Diversifying Electricity Generating Portfolios to Protect Themselves From Future Uncertainties

Five Star Equities Provides Stock Research on Duke Energy and The Southern Company

Continue Reading

Despite Cheap Prices Utilities Reluctant to Rely Heavily on Natural Gas

Five Star Equities Provides Stock Research on American Electric Power and Exelon

Continue Reading

Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements

Five Star Equities Provides Stock Research on Sunesis Pharmaceuticals and XOMA

Continue Reading

Despite Posting Mixed Fourth Quarter Earnings U.S. Airlines Showing Investors Strong Gains in 2013

Five Star Equities Provides Stock Research on Alaska Air Group and JetBlue Airways

Continue Reading

Biotech Industry Expected to Experience More M&A Activity in 2013

Five Star Equities Provides Stock Research on Array Biopharma and Venaxis

Continue Reading